Merck KGaA (MRK) Given a €99.00 Price Target at Goldman Sachs Group Inc.
Merck KGaA (FRA:MRK) has been assigned a €99.00 ($110.00) target price by equities researchers at Goldman Sachs Group Inc. in a research note issued to investors on Monday. The firm presently has a a “neutral” rating on the stock.
Other research analysts have also issued research reports about the company. Bankhaus Lampe set a €102.00 ($113.33) price target on Merck KGaA and gave the company a “buy” rating in a research report on Tuesday, July 19th. equinet AG set a €85.00 ($94.44) price target on Merck KGaA and gave the company a “buy” rating in a research report on Monday, July 18th. DZ Bank AG reaffirmed a “buy” rating on shares of Merck KGaA in a research report on Thursday, July 14th. Deutsche Bank AG set a €110.00 ($122.22) price target on Merck KGaA and gave the company a “buy” rating in a research report on Thursday, July 28th. Finally, Citigroup Inc. set a €115.00 ($127.78) price target on Merck KGaA and gave the company a “buy” rating in a research report on Tuesday, July 26th. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and ten have given a buy rating to the stock. Merck KGaA presently has a consensus rating of “Hold” and an average price target of €101.19 ($112.43).
Merck KGaA (FRA:MRK) opened at 97.40 on Monday. Merck KGaA has a 12 month low of €70.87 and a 12 month high of €100.00. The stock has a market cap of €42.35 billion and a PE ratio of 30.48. The company’s 50 day moving average price is €95.75 and its 200 day moving average price is €89.96.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/17/merck-kgaa-mrk-given-a-99-00-price-target-at-goldman-sachs-group-inc.html
About Merck KGaA
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.